The NORGANOID
Platform
The NanoLab System™ and the Organoid Factory™ are set to redefine pharmaceutical research by significantly lowering the cost of preclinical failures and enhancing clinical trial outcomes. This strategic use of organoids is aimed at facilitating the development of superior, more affordable drugs, offering profound benefits to both patients and the industry globally.
NanoLab SYSTEM
We are pioneering a scalable, automated organ-on-chip (OoC) system designed for high-content screening. This innovation offers a powerful tool for delving into complex biological interactions, minimizing manual labor, and providing a robust method for assessing the effectiveness of new treatments in conditions that closely mirror the clinical environment.
Going from 2D to 3D
Designed to streamline the challenging processes of organoid generation, in vitro drug screening, and imaging, the NLS™ offers a sophisticated alternative for expanding preclinical drug testing methods beyond traditional 2D cell cultures and animal models.
Plug-and-Play Solution
NLS™ is a plug-and-play solution adept at managing everything from initial iPSC differentiation to organoid culture maintenance, perfectly aligning with standard imaging techniques for phenotypic screening. For those keen to explore how NLS™ can cater to specific organoid types, please reach out to discover more about its versatile applications.
Cost-Efficiency
This OoC platform stands out from traditional automated cell culture systems by offering substantial cost benefits. It competently processes large organoid samples and reduces material use, thus significantly cutting down on capital expenditures relative to conventional robotic systems. This makes the NLS™ platform a cost-effective choice for diverse drug and chemical screening applications.
Enable R&D Goals
Boost your research and development capabilities with the NLS™, designed to minimize manual workload and maximize effectiveness. This allows your team to dedicate more time to innovation, speeding up the creation of groundbreaking therapies. For additional details on how the NLS™ can support your R&D objectives, please contact us.
Organoid factory™
As-a-service
Coming soon.
How to Work With Us
We are actively seeking commercial partners for collaboration on human organoid projects. If you’re interested in exploring potential opportunities, please contact us for a non-binding conversation.